Jansen, Sepp R. Dr.Universität HeidelbergHeidelberg
Refine publication list
Year of publication
Type of Publication
Language
Co-author (Univ. of Heidelberg)
Co-author (external)
Publications in heiBIB 
- Ma, Nan: Tankyrase inhibition interferes with junction remodeling, induces leakiness, and disturbs YAP1/TAZ signaling in the endothelium / Nan Ma, Yohanes Cakrapradipta Wibowo, Phillip Wirtz, Doris Baltus, Thomas Wieland & Sepp Jansen, 12 September 2023. - 27 S.
In: Naunyn-Schmiedeberg's archives of pharmacology, ISSN 1432-1912. 397(2023), 3, Seite 1763-1789
DOI: 10.1007/s00210-023-02720-1
- Jansen, Sepp R.: Paving the Rho in cancer metastasis : Rho GTPases and beyond / Sepp Jansen, Reinoud Gosens, Thomas Wieland, Martina Schmidt, 2018. - 21 S.
In: Pharmacology & therapeutics, ISSN 1879-016X. 183(2018) vom: März, Seite 1-21
DOI: 10.1016/j.pharmthera.2017.09.002
- Garg, Jaspal: Catecholamines facilitate VEGF-dependent angiogenesis via β2-adrenoceptor-induced Epac1 and PKA activation / Jaspal Garg, Yu-Xi Feng, Sepp R. Jansen, Julian Friedrich, Frank Lezoualc'h, Martina Schmidt and Tho… , April 20, 2017. - 17 S.
In: OncoTarget, ISSN 1949-2553. 8(2017), 27, Seite 44732-44748
DOI: 10.18632/oncotarget.17267
- Jansen, Sepp R.: Epac1 links prostaglandin E2 to β-catenin-dependent transcription during epithelial-to-mesenchymal transition / Sepp R. Jansen, Wilfred J. Poppinga, Wim de Jager, Frank Lezoualc'h, Xiaodong Cheng, Thomas Wieland,… , June 17, 2016. - 17 S.
In: OncoTarget, ISSN 1949-2553. 7(2016), 29, Seite 46354-46370
DOI: 10.18632/oncotarget.10128
